Columbia University Medical Center, Harkness Eye Institute, New York, NY.
New York University (NYU Robert Grossman) School of Medicine, NYU Langone Health, New York, NY.
Asia Pac J Ophthalmol (Phila). 2020 Jul-Aug;9(4):315-325. doi: 10.1097/APO.0000000000000295.
The aim of this study was to assess the benefit and feasibility of the teleophthalmology GlobeChek kiosk in a community-based program.
Single-site, nonrandomized, cross-sectional, teleophthalmologic study.
Participants underwent comprehensive evaluation that consists of a questionnaire form, brief systemic evaluation, screening visual field (VF), and GlobeChek kiosk screening, which included but not limited to intraocular pressure, pachymetry, anterior segment optical coherence tomography, posterior segment optical coherence tomography, and nonmydriatic fundus photography. The results were evaluated by a store-and-forward mechanism and follow-up questionnaires were obtained through phone calls.
A total of 326 participatents were screened over 4 months. One hundred thirty-three (40.79%) participants had 1 condition in either eye, and 47 (14.41%) had >1 disease. Seventy (21.47%) had glaucoma, 37 (11.34%) narrow-angles, 6 (1.84%) diabetic retinopathy, 4 (1.22%) macular degeneration, and 43 (13.10%) had other eye disease findings. Age >65, history of high blood pressure, diabetes mellitus, not having a dental examination >5 years, hemoglobn A1c measurement of ≥5.6, predibates risk score of ≥9, stage 2 hypertension, and low blood pressure were found to be significant risk factors. As for the ocular parameters, all but central corneal thickness, including an intraocular pressure >21 mm Hg, vertical cup to disc ratio >0.7, visual field abnormalities, and retinal nerve fiber layer thinning were found to be significant.
GlobeChek kiosk is both workable and effective in increasing access to care and identifying the most common causes of blindness and their risk factors.
本研究旨在评估基于社区的远程眼科 GlobeChek 亭在医疗中的获益和可行性。
单站点、非随机、横断面、远程眼科研究。
参与者接受全面评估，包括问卷调查表、简要系统评估、视野（VF）筛查和 GlobeChek 亭筛查，其中包括但不限于眼压、角膜厚度、眼前节光学相干断层扫描、后节光学相干断层扫描和免散瞳眼底照相。结果通过存储转发机制进行评估，并通过电话获得后续调查问卷。
在 4 个月内共筛查了 326 名参与者。133 名（40.79%）参与者的一只或两只眼中有 1 种疾病，47 名（14.41%）有>1 种疾病。70 名（21.47%）患有青光眼，37 名（11.34%）为窄角型，6 名（1.84%）患有糖尿病视网膜病变，4 名（1.22%）患有黄斑变性，43 名（13.10%）有其他眼部疾病发现。年龄>65 岁、高血压病史、糖尿病病史、>5 年未进行牙科检查、血红蛋白 A1c 测量值≥5.6、预测风险评分≥9、2 期高血压和低血压被认为是显著的危险因素。就眼部参数而言，除中央角膜厚度外，所有参数均有统计学意义，包括眼压>21mmHg、垂直杯盘比>0.7、视野异常和视网膜神经纤维层变薄。
GlobeChek 亭不仅可行而且有效，可以增加获得医疗服务的机会，并识别导致失明的最常见原因及其危险因素。
